When the Cure Causes the Disease: Organizational Iatrogenesis and the Action–Inaction Trap
Doctors have a word for harm caused not by the disease but by the treatment: iatrogenesis. The cure makes things worse. Organizations are no less prone to it. A central warning of the decision-error literature is that confident managerial interventions can unleash new, unpredictable problems — a phenomenon best understood as organizational iatrogenesis, where leaders inflict harm on their own organizations through their own decisions (Meckler & Boal, 2020).
The key insight: the most dangerous interventions are the confident, large-scale ones — because the system pushes back in ways no one modeled.
Harm from both directions
Leaders are squeezed between two kinds of error, and both cause real damage. Acting wrongly triggers cascading unintended consequences when an organization disrupts its own equilibrium based on flawed evidence (Meckler & Boal, 2020). But failing to act on a genuine problem is equally an error — the false-negative trap of ignoring a festering issue until it becomes a crisis (Meckler & Boal, 2020). There is no safe default. "Be bold" and "be cautious" are both wrong as blanket rules; the only sound aim is to act well.
Why confident fixes backfire
The paradox is that decisiveness — usually celebrated — is precisely what amplifies iatrogenic risk. When leaders confidently implement solutions based on illusions of validity, they inadvertently set off new organizational problems (Meckler & Boal, 2020). The bigger and more sweeping the intervention, the more of the system it perturbs, and the more places unintended consequences can erupt. Complexity makes this worse: systemic complexity and environmental instability greatly increase the likelihood of costly errors (Meckler & Boal, 2020).
The sales-leadership version
Every experienced sales leader has seen iatrogenesis up close. A compensation plan is "fixed" to drive new-logo acquisition — and reps abandon the existing base, so churn spikes and net revenue falls. A new CRM process is mandated to improve forecasting — and reps spend their selling time on data entry, so the pipeline shrinks. The intervention was confident, large-scale, and well-intentioned. It was also the disease.
How to intervene without harming
The remedy isn't paralysis; it's disciplined intervention.
- Model second-order effects. Before changing an incentive or process, ask "what will people do to game or route around this?"
- Pilot before you scale. A small test surfaces iatrogenic effects while they're still cheap to reverse.
- Monitor after acting. Since harm comes from disrupting equilibrium (Meckler & Boal, 2020), watch the system's response, not just the intended target.
- Stay humble about confidence. The certainty that justifies a sweeping fix is the same certainty that hides its side effects.
Where this fits in the SalesEvolution system
Sales systems are tightly coupled — comp, process, territory, and tooling all interact. Designing changes that improve results without triggering iatrogenic backlash is core to AI-assisted sales management, and it pairs with the reward-design cautions in rewarding A while hoping for B. Building leaders who intervene well is the work of our coaching and training programmes.
Every claim above links to its peer-reviewed source; browse the full research & sources.
Frequently asked questions
What is organizational iatrogenesis?
Borrowed from medicine — where iatrogenesis means harm caused by the treatment itself — organizational iatrogenesis describes harm that managers inflict on their own organizations through their decisions and interventions. The 'cure' creates new, often worse, problems than the one it was meant to solve.
What is the action–inaction trap?
Leaders face harm from two directions: errors of commission (acting wrongly and triggering unintended damage) and errors of omission (failing to act on a real problem). Both are genuine decision errors, so the goal is not simply to 'be decisive' or 'be cautious' but to act well — with awareness of how interventions can backfire.
How can leaders reduce iatrogenic harm?
By anticipating second-order consequences before intervening, piloting changes before scaling them, monitoring for unintended effects after acting, and cultivating the humility to recognize that confident large-scale fixes are exactly the ones most likely to disrupt a system in unforeseen ways.
Shadow AI in Sales: Your Reps Are Already Using It — The Only Question Is Whether You Know
Across B2B sales teams, reps are quietly pasting deals, emails, and call notes into ChatGPT and other tools their company never sanctioned. This is 'shadow AI' — and the research is clear that punishing it only drives it deeper underground. Here's how to surface it and turn it into an advantage.
Building a Digital Sales Strategy: Why AI Can't Be a Bolt-On
AI delivers results only inside a cohesive, organization-wide sales strategy — never as a tactical add-on. That means defining your goals for AI, aligning it to your value proposition, integrating sales, marketing, and IT, auditing your infrastructure, and updating the KPIs you measure success by.
Put this into practice
See how SalesEvolution applies these methods to your pipeline. Start with a free 30-minute strategy consultation.
Book a strategy consult →